Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 2,859.10
-15.40 (-0.54%)
At close: Dec 15, 2025
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 240.17 billion as of December 15, 2025. Its market cap has decreased by -4.92% in one year.
Market Cap
240.17B
Enterprise Value
229.05B
Revenue
26.00B
Ranking
n/a
PE Ratio
44.83
Stock Price
2,859.10
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 240.17B, an increase of 252.25%. That is a compound annual growth rate of 13.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 238.88B | -4.45% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | 190.13B | 54.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 934.94B |
| Mankind Pharma | 899.42B |
| Aurobindo Pharma | 694.12B |
| Alkem Laboratories | 673.27B |